Dr. Inglesby was appointed CEO and Director of the Center for Biosecurity of UPMC in November 2009. He served as Chief Operating Officer and Deputy Director from 2004 to 2009, and was one of the Center’s founding members in 1998. 

Dr. Inglesby is an internationally recognized biosecurity expert whose work over the past decade has helped shape the development of the field. He played a leading role in all of the Center’s high-impact initiatives, including the Atlantic Storm and Dark Winter exercises and a series of seminal JAMA articles on the medical and public health response to the most dangerous biological agents. Dr. Inglesby has played a central role in development of the Center’s strategic priorities and programs over the years. He has expanded and deepened the Center’s expertise in biosecurity while at the same time establishing new initiatives to improve response to emerging infectious diseases and natural disasters, as well as preparedness for nuclear terrorism and radiation disasters.

Dr. Inglesby was recently named Chair of the Board of Scientific Counselors to CDC’s Office of Public Health Preparedness and Response. He has been chair or a member of a number of National Academy of Sciences committees, and he has served in an advisory capacity to the Defense Science Board, the Departments of Health and Human Services and Homeland Security, the National Institutes of Health, and the Office of the Director of National Intelligence. Most recently, in 2009-2011, Dr. Inglesby was a member of the National Academy of Sciences expert committee that reviewed the scientific approaches used during the investigation of the 2001 anthrax letters.

Dr. Inglesby has been invited to brief White House officials from the past 3 presidential administrations on national biosecurity challenges and priorities, and he has delivered Congressional testimony on biological threats and preparedness.

Since 1999, Dr. Inglesby has authored or co-authored more than 75 peer-reviewed articles, reports, and commentaries on a wide range of public health and national security issues. In 2010, he co-authored “Necessary Progress in Biosecurity” with Senator Tom Daschle for the Harvard Law and Policy Review. He is Coeditor-in-Chief of the journal Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, which he helped to establish in 2003 as the only peer-reviewed journal in the field. In addition, Dr. Inglesby was principal editor of the 2002 JAMA book Bioterrorism: Guidelines for Medical and Public Health Management. He is regularly consulted by major news outlets for his expertise and insight on issues pertaining to biosecurity, biodefense, and response to public health disasters.

Dr. Inglesby is an Associate Professor of Medicine and Public Health at the University of Pittsburgh Schools of Medicine and Public Health. He completed his internal medicine and infectious diseases training at Johns Hopkins University School of Medicine, where he also served as Assistant Chief of Service in 1996-97. Dr. Inglesby received his MD from Columbia University College of Physicians and Surgeons and his BA from Georgetown University.